End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
181,800 KRW | -1.46% | +2.83% | -9.78% |
Jul. 01 | S.Korean shares rise on robust data; battery, biopharma stocks jump | RE |
Jun. 17 | Celltrion Reveals Positive Phase III Results of Rheumatoid Arthritis Drug | MT |
MarketScreener Editorial Features
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- MarketScreener Editorial Features